Discovery of T-1101 tosylate as a first-in-class clinical candidate for Hec1/Nek2 inhibition in cancer therapy by Chuang, Shih-Hsien, Lee, Ying-Shuan E., Huang, Lynn Y.L., Chen, Chi-Kuan, Lai, Chun-Liang, Lin, Yu-Hsiang, Yang, Ju-Ying, Yang, Sheng-Chuan, Chang, Lien-Hsiang, Chen, Ching-Hui, Liu, Chia-Wei, Lin, Her-Sheng, Lee, Yi-Ru, Huang, Kuan Pin, Fu, Kuo Chu, Jen, Hsueh-Min, Lai, Jun-Yu, Jian, Pei-Shiou, Wang, Yu-Chuan, Hsueh, Wen-Yun, Tsai, Pei-Yi, Hong, Wan-Hua, Chang, Chia-Chi, Wu, Diana ZC, Wu, Jinn, Chen, Meng-Hsin, Yu, Kuo-Ming, Chern, Ching Yuh, Chang, Jia-Ming, Lau, Johnson Y.N., Huang, Jiann-Jyh

Get full text

Discovery of 4‑Aryl‑N‑arylcarbonyl-2-aminothiazoles as Hec1/Nek2 Inhibitors. Part I: Optimization of in Vitro Potencies and Pharmacokinetic Properties by Lee, Ying-Shuan E, Chuang, Shih-Hsien, Huang, Lynn Y. L, Lai, Chun-Liang, Lin, Yu-Hsiang, Yang, Ju-Ying, Liu, Chia-Wei, Yang, Sheng-chuan, Lin, Her-Sheng, Chang, Chia-chi, Lai, Jun-Yu, Jian, Pei-Shiou, Lam, King, Chang, Jia-Ming, Lau, Johnson Y. N, Huang, Jiann-Jyh

Get full text